USCDI’s Latest Version Aims to Improve Treatments Announcement The Assistant Secretary for Technology Policy (ASTP) announced the latest version of United States Core Data for Interoperability (USCDI) on July 24, 2025. USCDI is also globally known as USCDI v6. The office of the national ...
Lilly and Gate Bioscience Partnered to Advance Molecular Gate Medicines Announcement Gate Bioscience, a leading biotechnology company advancing molecular gates, a new class of small molecule drugs to discard disease-related proteins at their source, has signed a license agreement and partnered...
Plug and Play New Healthcare Program in Orlando Announcement Plug and Play, a global innovation platform, will be launching a healthcare program in Orlando, Florida. Under the partnership with Orlando Health, KPMG LLP, and Guidewell, the program will be inviting around 10 to 12 startups in its...
Washington University in St Louis and MilliporeSigma Appeared Together to Bolster Scientific Collaboration Announcement The Milliporesigma, the Canadian life science and the US business of Merck KGaA, Darmstadt, Germany, a popular technology and science company, entered into a contract, signin...
Xenetic Biosciences to Extend R&D Agreement with the Scripps Research Institute Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company popularly known for its innovative immune-oncology technologies to identify difficult oncology indications, has extended its collaborativ...
Global RDH12 Alliance and Opus Genetics Entered a Partnership Agreement Announcement Global RDH12 alliance and Opus Genetics Inc., a biopharmaceutical company accelerating gene therapies for the treatment of small-molecule therapies and inherited retinal disease (IRDs) for other ophthalmic disor...
Tharimmune’s Common Stocks and Warrants are Now Available for Purchase Announcement Tharimmune Inc. (Tharimmune and the company), a biotechnological company, a leader for therapies in inflammation and immunology, has revealed the price of its registered direct public offering with a few pu...
Caravan Biologix Received a Research License for the KOMbine™ Platform Announcement KOMO Biosciences, a known precision genome engineering offered a research license to Caravan Biologix, a commendable innovator in advancing mini-CAR technology, and a miniature T-cell that holds the natural...
Kansai and Alloy are in a Collaboration to Leverage Growth in Japan Announcement Kansai Startup Academia Coalition, represented by Kyoto University, fostered to expansion university university-affiliated life science startups throughout Japan, and Alloy Therapeutics co, Ltd. has signed a memoran...
QIAGEN Enhances its Portfolio with Long-read Panels Announcement Qiagen has introduced new QIAseq xHYB long-read panels, a groundbreaking solution designed to explore the long-read sequencing of genomically complex regions. This sequencing idea strongly builds Qiagen’s position as a provid...
